HF
IMCR icon

HRT Financial’s Immunocore IMCR Stock Holding History

HRT Financial’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$689K Sell
22,861
-9,735
-30% -$315K ﹤0.01% 2299
2025
Q4 		$1.13M Buy
32,596
+23,800
+271% +$840K ﹤0.01% 1644
2025
Q3 		$319K Sell
8,796
-6,248
-42% -$212K ﹤0.01% 2132
2025
Q2 		$472K Buy
+15,044
New +$467K ﹤0.01% 1633
2024
Q4 		– Sell
-6,479
Closed -$201K – 2795
2024
Q3 		$201K Buy
+6,479
New +$236K ﹤0.01% 1974
2024
Q1 		– Sell
-20,921
Closed -$1.43M – 2652
2023
Q4 		$1.43M Buy
20,921
+7,639
+58% +$397K 0.01% 815
2023
Q3 		$689K Buy
+13,282
New +$786K 0.01% 1219

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

HRT Financial's IMCR Position: Q1 2026 in Review

HRT Financial reduced its Immunocore (IMCR) stake by 30% in Q1 2026, selling an estimated $315K and leaving 22,861 shares worth $689K. The position accounts for ﹤0.01% of the portfolio, ranked #2299.

HRT Financial first reported a position in IMCR in Q3 2023 and has held it in 7 quarters since. The position peaked at $1.43M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • HRT Financial held 22,861 shares of Immunocore worth $689K as of Q1 2026.
  • HRT Financial sold 9,735 Immunocore shares in Q1 2026, an estimated $315K.
  • Immunocore made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #2299 holding.
  • HRT Financial first reported a position in Immunocore in Q3 2023 and has held it in 7 quarters since.
  • HRT Financial's Immunocore position peaked at $1.43M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.